Task: Answer the multiple-choice question.
Question: Which drug exhibits a 2.835% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CC(C)(C)C(=O)Nc1nnc(CC(=O)NCc2ccccc2)s1
b O=C(NC1CCN(C(=O)NC2CCCCC2)CC1)c1cccc(F)c1
c COc1cc(NCCC(=O)c2cccs2)c(OC)cc1Cl
d Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2)cc1C
Answer: a. CC(C)(C)C(=O)Nc1nnc(CC(=O)NCc2ccccc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)C(=O)Nc1nnc(CC(=O)NCc2ccccc2)s1
CC(C)(C)C(=O)Nc1nnc(CC(=O)NCc2ccccc2)s1
N-[5-[2-(benzylamino)-2-oxoethyl]-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide